Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW41B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,048
Award facts
- Contract value 100% obligated
- $22,047.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $22,047.86 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units). This firm fixed-price delivery order, which carries an ultimate completion date of January 15, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the broad pharmaceutical supply requirements of the federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical extending through December 31, 2031. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The award demonstrates AmerisourceBergen's continued role as a critical vendor for federal medical procurement, serving military treatment facilities and veteran healthcare programs with essential pharmaceutical commodities through open and competitive contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26FW41B?
SPE2DR26FW41B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FW41B worth?
The government has obligated $22,048 on SPE2DR26FW41B.
Is contract SPE2DR26FW41B an order under another contract?
Yes. SPE2DR26FW41B is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW41B competed?
The extent of competition for SPE2DR26FW41B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award